CollPlant Biotechnologies (NASDAQ:CLGN – Get Free Report) and United Health Products (OTCMKTS:UEEC – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.
Earnings & Valuation
This table compares CollPlant Biotechnologies and United Health Products’ revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| CollPlant Biotechnologies | $10.62 million | 4.83 | -$7.02 million | ($0.68) | -6.59 |
| United Health Products | $40,000.00 | 939.69 | -$2.62 million | N/A | N/A |
United Health Products has lower revenue, but higher earnings than CollPlant Biotechnologies.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| CollPlant Biotechnologies | 0 | 0 | 1 | 1 | 3.50 |
| United Health Products | 0 | 0 | 0 | 0 | N/A |
CollPlant Biotechnologies currently has a consensus price target of $11.00, suggesting a potential upside of 145.54%. Given CollPlant Biotechnologies’ higher possible upside, equities analysts plainly believe CollPlant Biotechnologies is more favorable than United Health Products.
Risk & Volatility
CollPlant Biotechnologies has a beta of 0.24, indicating that its stock price is 76% less volatile than the S&P 500. Comparatively, United Health Products has a beta of -0.37, indicating that its stock price is 137% less volatile than the S&P 500.
Profitability
This table compares CollPlant Biotechnologies and United Health Products’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| CollPlant Biotechnologies | -70.58% | -24.74% | -20.90% |
| United Health Products | N/A | N/A | -600.31% |
Insider & Institutional Ownership
21.7% of CollPlant Biotechnologies shares are held by institutional investors. Comparatively, 0.1% of United Health Products shares are held by institutional investors. 9.6% of CollPlant Biotechnologies shares are held by insiders. Comparatively, 1.5% of United Health Products shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
CollPlant Biotechnologies beats United Health Products on 8 of the 12 factors compared between the two stocks.
About CollPlant Biotechnologies
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.
About United Health Products
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.
Receive News & Ratings for CollPlant Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CollPlant Biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
